Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]

Total article views   HTML views PDF downloads Totals
2,588 Dovepress* 2,531+ 171 2,702
PubMed Central* 57 41 98
Totals 2,588 212 2,800
*Since 3 August 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar